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Summary
 
Leukocyte telomere length (LTL) is ostensibly a bio-
indicator of human aging. Here we report that African
Americans have longer LTL than whites. We studied cross-
sectionally 2453 individuals from the National Heart,
Lung, and Blood Institute (NHLBI) Family Heart Study
(age = = = =
 
  30–93  years) and the Bogalusa Heart Study
(age = = = =
 
 19–37 years), comprising 1742 whites and 711 Afri-
can Americans. We measured LTL by Southern blots of the
terminal restriction fragments length. In 234 participants,
telomere repeats were also measured by quantitative
polymerase chain reaction (qPCR). Adjusted for age and
body mass index (BMI), the respective leukocyte telomere
lengths (mean ± ± ± ±
 
 SEM) were considerably longer in African
Americans than in whites both in the Family Heart Study
(7.004 ± ± ± ±
 
 0.033 kb vs. 6.735 ± ± ± ±
 
 0.024 kb, p < < < <
 
 0.0001) and the
Bogalusa Heart Study (7.923 ± ± ± ±
 
 0.063 kb vs. 7.296 ± ± ± ±
 
 0.039 kb,
p < < < <
 
 0.0001). We confirmed the racial effect on LTL by qPCR
(3.038 ± ± ± ±
 
 0.565 T/S units for African Americans vs. 2.714 ± ± ± ±
 
0.487 T/S units for whites, p < < < <
 
 0.001). Cross-sectionally,
sex- and BMI-adjusted LTL became shorter with age (range
19–93 years) at a steeper slope in African Americans than
in whites (0.029 kb year–1 vs. 0.020 kb year–1, respectively,
p = = = =
 
 0.0001). We suggest that racial difference in LTL arises
from a host of interacting biological factors, including
replication rates of hematopoietic stem cells.
Key words: age; demography; gender; leukocyte; race;
telomere.
 
Introduction
 
Mounting evidence suggests that leukocyte telomere length
(LTL) is a bio-indicator of human aging, cardiovascular aging in
particular. LTL is heritable (Slagboom 
 
et
 
 
 
al
 
., 1994; Jeanclos
 
et
 
 
 
al
 
., 2000; Vasa-Nicotera 
 
et
 
 
 
al
 
., 2005; Andrew 
 
et
 
 
 
al
 
., 2006),
although it is unknown how much of this heritability relates
to birth LTL and the rate of its shortening from birth onward.
Age-dependent LTL shortening is due to successive divisions of
hematopoietic stem cells (HSCs) and progenitor cells (PCs) that
form peripheral leukocytes. Inflammation and oxidative stress
– two central elements in the biology of aging and aging-related
diseases (Finch & Crimmins, 2004; Balaban 
 
et
 
 
 
al
 
., 2005) – were
reported to be associated with LTL (Aviv 
 
et
 
 
 
al
 
., 2006a; Demissie
 
et
 
 
 
al
 
., 2006; Bekaert 
 
et
 
 
 
al
 
., 2007; Fitzpatrick 
 
et
 
 
 
al
 
., 2007).
Inflammation entails an increase in number and diminished
biological life of leukocyte subsets in the circulation, which would
heighten the demand on HSCs/PCs to replicate, a phenomenon
expressed in an accelerated telomere attrition and ultimately
shortened LTL. Oxidative stress heightens the loss of telomere
repeats per cell division (Sitte 
 
et
 
 
 
al
 
., 1998; Saretzki 
 
et
 
 
 
al
 
., 1999;
Tchirkov & Lansdorp, 2003). The compounded effect of inflam-
mation/oxidative stress on the paces of both aging and LTL
attrition conceivably explains the shortened LTL observed in
individuals with aging-related diseases, particularly atherosclerotic
cardiovascular (CV) disease (Brouilette 
 
et
 
 
 
al
 
., 2003; Cawthon
 
et
 
 
 
al
 
., 2003; Benetos 
 
et
 
 
 
al
 
., 2004; Martin-Ruiz 
 
et
 
 
 
al
 
., 2005;
Matsubara 
 
et
 
 
 
al
 
., 2006; Brouilette 
 
et
 
 
 
al
 
., 2007; Fitzpatrick 
 
et
 
 
 
al
 
.,
2007; van der Harst 
 
et
 
 
 
al
 
., 2007), which is strongly linked to
inflammation (Hansson & Libby, 2006).
The paradigm that links LTL to CV disease draws on data
derived mainly from non-African American populations. But the
developmental pattern of CV disease differs between African
Americans and whites. For instance, African  Americans are
more prone to heart failure due to hypertension (Yancy, 2005;
Whittle 
 
et
 
 
 
al
 
., 2006), but they have considerably less coronary
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artery calcification than do whites (Tang 
 
et
 
 
 
al
 
., 1995; Yan 
 
et
 
 
 
al
 
.,
2006; McClelland 
 
et
 
 
 
al
 
., 2006; Aiyer 
 
et
 
 
 
al
 
., 2007; Loria 
 
et
 
 
 
al
 
., 2007).
We therefore explored in two ongoing studies, the National Heart,
Lung, and Blood Institute (NHLBI) Family Heart Study (FHS) and
the Bogalusa Heart Study (BHS), the racial effect on LTL.
 
Results
 
Mean ages and BMI of whites and African Americans, by sex,
are displayed in Table 1. In both the FHS and the BHS cohorts,
LTL, measured by Southern blots of the terminal restriction
fragment (TRF) products of 
 
Hin
 
fI/
 
Rsa
 
I, was significantly longer
in African Americans than in whites (Table 2; Fig. 1). As LTL was
inversely correlated to BMI (
 
r
 
 
 
=
 
 –0.071, 
 
p 
 
=
 
 0.002), we adjusted
LTL for the BMI. For the FHS cohort, sex-specific differences in
age- and BMI-adjusted LTL between African  Americans and
whites were 180 base pairs (bp) for men and 320 bp for women;
for the BHS cohort, these differences amounted to 500 bp
for men and 680 bp for women. Heritability of LTL in whites
was 0.69 
 
±
 
 0.03, while in African Americans it was 0.78 
 
±
 
 0.09,
both significant at 
 
p
 
 
 
<
 
 0.0001. There was no statistically
significant difference in heritability between African Americans
and whites.
In the FHS cohort, women of both races displayed significantly
longer LTL than men (Table 2; Fig. 1). The sex-related differences
in age- and BMI-adjusted LTL for this cohort were 120 bp for
Table 1 Means (± standard deviation) of age and body mass index of the two cohorts
Whites African Americans Entire sample
Men Women Men Women Men Women
FHS (n = 610) (n = 785) (n = 195) (n = 378) (n = 805) (n = 1163)
Age (years) 57.3 ± 13.6 58.5 ± 13.1 52.4 ± 10.6 54.0 ± 10.9 56.1 ± 13.1 57.1 ± 12.6
Body mass index (kg m
–2) 29.4 ± 4.7 28.4 ± 5.9 30.6 ± 6.1 34.1 ± 7.8 29.7 ± 5.1 30.2 ± 7.1
BHS (n = 140) (n = 207) (n = 44) (n = 94) (n = 184) (n = 301)
Age (years) 30.9 ± 4.6 30.1 ± 4.8 31.6 ± 3.9 29.4 ± 5.0 31.1 ± 4.4 30.0 ± 4.9
Body mass index (kg m
–2) 27.8 ± 5.3 25.5 ± 6.1 28.6 ± 8.2 30.6 ± 8.6 28.0 ± 6.1 27.1 ± 7.4
BHS, Bogalusa Heart Study; FHS, Family Heart Study.
Table 2 Leukocyte telomere parameters by race and sex in the two cohorts, in which leukocyte telomere length (LTL) was measured using restriction enzymes 
HinfI/RsaI
Whites African Americans
p gender p race Men Women Men Women
FHS
LTL 6.67 ± 0.03 6.77 ± 0.03 6.93 ± 0.05 7.16 ± 0.04 < 0.0001 < 0.0001
Age-adjusted LTL 6.68 ± 0.03 6.81 ± 0.03 6.86 ± 0.05 7.10 ± 0.03 < 0.0001 < 0.0001
Age- and BMI-adjusted LTL 6.68 ± 0.03 6.80 ± 0.03 6.86 ± 0.04 7.12 ± 0.04 < 0.0001 < 0.0001
BHS
LTL 7.28 ± 0.06 7.32 ± 0.05 7.81 ± 0.10 7.95 ± 0.08 0.5087 < 0.0001
Age-adjusted LTL 7.29 ± 0.06 7.31 ± 0.05 7.83 ± 0.11 7.93 ± 0.08 0.5241 < 0.0001
Age- and BMI-adjusted LTL 7.30 ± 0.06 7.29 ± 0.05 7.84 ± 0.11 7.97 ± 0.08 0.2590 < 0.0001
BMI, body mass index; BHS, Bogalusa Heart Study; FHS, Family Heart Study.
Fig. 1 Age- and body mass index-adjusted 
leukocyte telomere length (LTL) in the NHLBI Family 
Heart Study (FHS) and the Bogalusa Heart Study 
(BHS), based on terminal restriction fragment 
lengths, determined in the entire sample by HinfI/
RsaI restriction enzymes. The lower LTL values in the 
FHS than the BHS cohorts relate to the older age 
of the participants of the FHS.Race and leukocyte telomere length, S. C. Hunt et al.
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whites and 260 bp for African Americans. However, no such
difference was noted between women and men of both races
in the relatively younger BHS cohort (Table 2; Fig. 1). Further
details regarding LTL results derived from the HinfI/RsaI digest
are summarized in Table 2.
In most clinical studies, the restriction enzymes for TRF analysis
typically comprise HinfI/RsaI. In principle, longer LTL in African
Americans than in whites may arise from race-related poly-
morphisms in length or the nearest restriction site proximal
to the canonic (TTAGGG) stretch of the telomeric repeats. For
this reason we also measured in a subset of the BHS cohort TRF
length using the restriction enzymes HphI/MnII. Both restriction
enzymes HinfI/RsaI and HphI/MnII yield an admixture of TRFs
comprising primarily canonical but also some noncanonical
telomere repeats at the proximal region of the telomeres.
However, HphI/MnII cut the DNA at TGAGGG and TCAGGG,
yielding shorter TRFs than those generated by HinfI/RsaI (Allshire
et al., 1989; Baird et al., 2006). This is shown in Fig. 2 and Table 3
(and in Supplementary Fig. S1). In this subset, we also measured
telomeric DNA content by quantitative polymerase chain
reaction (qPCR) analysis, which strictly quantifies telomere
repeats. Regardless of the method used, African Americans
displayed longer LTL (or a higher T/S ratio) than whites (Fig. 2;
also see Table 3). We note that the qPCR method (Cawthon,
2002) has a higher CV% than the TRF length analysis, which
might limit detection of small variation in telomere length (Aviv
et al., 2006b). However, given the considerable difference in
LTL between African Americans and whites, the qPCR measure-
ments confirmed the findings of the TRF length analysis.
Interestingly, analysis of the TRF products generated by the HphI/
MnII digest showed a significant sex effect on LTL in the BHS.
We also obtained the overall and differential counts of
leukocytes and their subsets, including neutrophils, in the
majority of participants of the BHS whose telomere parameters
were measured (Supplementary Table  S1). Although African
Americans showed significantly lower leukocyte and neutrophil
Fig. 2 Age- and body mass index-adjusted leukocyte telomere length (LTL) in a subset of the Bogalusa Heart Study (BHS) based on terminal restriction fragment 
lengths, determined by using restriction enzymes HinfI/RsaI and HphI/MnII, and by quantitative polymerase chain reaction. Figure displays results from 72 men 
and 162 women, equally divided by race.
Table 3 Leukocyte telomere parameters in a subset of the Bogalusa Heart Study by race and sex in which leukocyte telomere length (LTL) and telomere repeats 
were measured using restriction enzymes HinfI/RsaI and HphI/MnII, and by quantitative polymerase chain reaction (qPCR)
Bogalusa Heart Study
Whites African Americans
p-value 
gender
p-value 
race Men Women Men Women
LTL (HinfI/RsaI) (kb)
Unadjusted 7.15  ± 0.13 7.25 ± 0.08 7.80 ± 0.11 7.91 ± 0.08 0.4702 < 0.0001
Age-adjusted 7.16  ± 0.12 7.24 ± 0.08 7.81 ± 0.12 7.91 ± 0.08 0.3878 < 0.0001
Age- and BMI-adjusted  7.14 ± 0.12 7.20 ± 0.08 7.82 ± 0.12 7.95 ± 0.08 0.3748 < 0.0001
LTL (HphI/MnII) (kb)
Unadjusted 5.59  ± 0.13 5.79 ± 0.08 6.07 ± 0.13 6.32 ± 0.08 0.0292 < 0.0001
Age-adjusted 5.61 ± 0.12 5.78 ± 0.08 6.08 ± 0.12 6.31 ± 0.08 0.0637 < 0.0001
Age- and BMI-adjusted 5.58 ± 0.13 5.74 ± 0.08 6.10 ± 0.12 6.34 ± 0.08 0.0503 < 0.0001
qPCR LTL (T/S units)
Unadjusted 2.71  ± 0.08 2.71 ± 0.05 3.01 ± 0.10 3.05 ± 0.06 0.7923 < 0.0001
Age-adjusted 2.69 ± 0.09 2.72 ± 0.06 2.99 ± 0.08 3.06 ± 0.06 0.4788 < 0.0001
Age- and BMI-adjusted 2.68 ± 0.09 2.70 ± 0.06 2.99 ± 0.09 3.08 ± 0.06 0.4449 < 0.0001
BMI, body mass index.Race and leukocyte telomere length, S. C. Hunt et al.
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counts than did whites, no relationships were observed between
these counts and LTL in African  Americans and whites,
independently or jointly.
Figure 3 displays sex- and BMI-adjusted LTL vs. age from the
combined data set of the FHS and BHS, using LTL derived from
HinfI/RsaI digest. African Americans had higher LTL at nearly all
ages. However, sex- and BMI-adjusted LTL became shorter with
age at a steeper slope in African Americans (0.029 kb year
–1)
than in whites (0.020 kb year
–1) (p = 0.0001). The slope of LTL
vs. age did not differ by sex.
Discussion
The central finding of this study is that African Americans have
considerably longer LTL than whites, at least up to age 80. In
this study, we observed a sex effect on LTL in the NHLBI FHS,
but in the BHS, the sex effect was found only in the products
of the HphI/MnII. A potential explanation for the difficulty in
detecting the sex effect may be the much younger age of the
BHS participants. In the FHS and in previous studies that found
longer LTL in women than men (Jeanclos et al., 2000; Benetos
et al., 2001; Nawrot et al., 2004; Vasa-Nicotera et al., 2005;
Bekaert et al., 2007), the subjects were much older than those
in the BHS.
LTL is equal in African American and white newborns (Okuda
et al., 2002). As African Americans in their 20s already display
longer LTL than their white peers, the racial gap in LTL might
relate to factors that define leukocyte telomere dynamics during
the formative years. These include the proliferative rates of
HSCs/PCs. African Americans and other individuals of African
ancestry display lower leukocyte and neutrophil counts than do
whites (Haddy et al., 1999; Bain et al., 2000; Phillips et al.,
2000; Mayr et al., 2007), a finding we confirmed in the BHS.
The neutrophils in peripheral blood are distributed into two
pools; namely, circulating cells and marginated cells that adhere
to the endothelium in postcapillary venules (Athens et al., 1961).
Physiological neutropenia in individuals of African ancestry is
not due to increased margination of neutrophils (Athens et al.,
1961; Bain et al., 2000; Phillips et al., 2000). It is therefore likely
to arise from fewer replications of HSCs/PCs. The longer LTL in
African Americans than in whites is consistent with this premise.
Telomere length is shorter in neutrophils than in T lymphocytes
in young individuals and vice versa in older individuals (Weng,
2001). For the following reasons, we suggest that in and of itself
this phenomenon does not explain the racial difference in LTL:
First, LTL was found to be longer in African Americans than in
whites at a wide age range that encompasses most of adult
life. Second, there are considerable interindividual variations in
LTL at birth (Okuda et al., 2002; Akkad et al., 2006) and there-
after (Jeanclos et al., 2000; Benetos et al., 2001; Gardner et al.,
2005; Nawrot et al., 2005; Valdes et al., 2005; Vasa-Nicotera
et al., 2005; Bekaert et al., 2007; Njajou et al., 2007). These
interindividual variations in telomere length far exceed the
variation in telomere length among cell types within the
individual, because telomere length is synchronized (equivalent)
in different tissues and cells in the fetus (Youngren et al., 1998)
and the newborn (Okuda et al., 2002), and partially synchronized
at any age (Butler et al., 1998; Martens et al., 1998; von Zglinicki
et al., 2000; Takubo et al., 2002; Gardner et al., 2007). It follows
that individuals with relatively long (or short) telomere length
in one cell type have long (or short) telomere length in other
cell types. Regarding telomere dynamics in leukocytes, LTL
reflects birth telomere length and replicative history of HSCs/
PCs. At any given time, and for whatever reason and duration,
an altered demand by a leukocyte subset on PCs to increase or
diminish their divisions would ultimately impact telomere dynamics
in HSCs and therefore telomere length in all leukocytes. It is
unlikely therefore that the racial differences in LTL may be simply
explained by a subset of leukocytes. Third, in the BHS we found
no association of LTL with the numbers of either leukocytes or
neutrophils (Supplementary Table S1). This is not unexpected,
as LTL is a record of the replicative history of HSCs/PCs over the
individual’s lifetime until sample collection, while the leukocyte
and neutrophil counts reflect a ‘snapshot’ of the peripheral
leukocytes at the time of sample collection.
Although diminished HSC/PC replication might explain the
longer LTL in African  Americans than in whites during early
adulthood, additional factors apparently tip the balance towards
narrowing the racial gap in LTL later in life. Theoretical consid-
erations suggest that telomere attrition rate in cultured cells is
proportional to telomere length (op den Buijs et al., 2004),
perhaps because longer telomeres are a greater target to free
radicals. All other things being equal, the relatively longer LTL
in adult African Americans may account in part for a higher rate
of LTL shortening. In addition, African Americans exhibit increased
prevalence of risk factors – not only for CV disease (whose
pattern may not be the same as in whites), but also for other
potentially deleterious conditions, e.g. low social status and
Fig. 3 Sex- and body mass index-adjusted leukocyte telomere length (LTL) vs. 
age for African Americans and whites from the NHLBI Family Heart Study 
(FHS) and the Bogalusa Heart Study (BHS) combined.Race and leukocyte telomere length, S. C. Hunt et al.
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unhealthy lifestyle (Otten et al., 1990), which were shown to
be associated with shortened LTL (Cherkas et al., 2006; Bekaert
et al., 2007). Despite the racial differences in LTL and the rate
of its shortening during adulthood, we found LTL to be heritable
in both races.
Might the longer LTL in African Americans than whites
provide clues with regard to racial differences in life expectancy
in the USA? Until recently, a controversy existed about the
relation between LTL and mortality/survival in elderly persons
(Cawthon et al., 2003; Martin-Ruiz et al., 2005; Bischoff et al.,
2006; Harris et al., 2006; Honig et al., 2006). Of these, two
studies (Cawthon et al., 2003; Honig et al., 2006) showed an
association between mortality and LTL. The other three did not.
We recently addressed this question in the Longitudinal Study
of Aging Danish Twins, which comprises same-sex, elderly
twins, whose mortality/survival was monitored for 10 years
after leukocyte collection. The same-sex twin model is the
most optimal to study the connection between mortality and
LTL because it controls for genes, rearing environment, sex
and age, all of which might impact LTL. Using Southern blot
analysis approach, it was found that the co-twin with the shorter
telomere parameters was likely to die first by the 4th year of the
10 years  follow-up (Kimura et al., in press). Another study
reported similar findings in same-sex Swedish twins (Bakaysa
et al., 2007).
The mechanisms that define the upper boundary of lifespan
– namely, the survival of elderly individuals who withstood or
did not suffer aging-related diseases during midlife – might not
be the same as those that determine aging in the general
population (Kimura et al., 2007). However, assuming that LTL
is associated with lifespan in the elderly, there are curious
observations regarding differences in mortality/survival between
African Americans and whites. African Americans exhibit increased
clustering of risk factors not only for CV disease but also other
potentially lethal maladies; in the USA they display higher
mortality rates and shorter life expectancy than whites (Otten
et al., 1990). However, above the age of 70–80 years African
Americans have been reported to exhibit lower mortality than
whites (Markides & Machalek, 1984; Wing et al., 1985; Ford
et al., 1990; Elo & Preston, 1994). This crossover phenomenon
was challenged due to concerns that vital statistics data reflect
systematic misreporting of age among elderly African Americans
(Coale & Kisker, 1986; Preston et al., 1996). However, more recent
work further supports the mortality crossover, at least with
respect to coronary heart disease mortality (Corti et al., 1999).
The etiology of this finding is unknown. The faster LTL short-
ening in African Americans would narrow the racial difference
in LTL, but the vestigial effect of the LTL ‘advantage’ in African
Americans throughout most of adult life might narrow the racial
gap in mortality in the elderly.
A number of limitations of this study are noteworthy. First, this
cross-sectional study is not as powerful as the longitudinal
approach to examine leukocyte telomere dynamics. Second, our
conclusions that LTL attrition rate is slower in African Americans
than in whites between birth and early adulthood is based on
indirect evidence. Third, our study focuses on the racial difference
in LTL without factoring a host of race-associated circumstances
that might account for the narrowing of the racial gap in LTL. How-
ever, the racial difference in LTL is of such a magnitude that it would
probably eclipse the effect of any single environmental factor.
We propose that race and ethnicity should be assessed in
future studies that explore the associations between diseases
of aging, CV disease, in particular, and leukocyte telomere parameters.
Experimental procedures
The cohorts
The NHLBI FHS is a multicenter investigation of the genetic and
epidemiologic basis of CV disease (Higgins et al., 1996). Between
January 2002 and January 2004, 3359 family members were studied
(2737 whites, 622 African Americans). The LTL data are derived from
1968 individuals from this cohort (1163 women, 805 men, 1395
whites and 573 African Americans) with an age range of 30–93 years.
The BHS is a long-term community-based epidemiologic study
of early natural history of CV disease beginning in childhood
from the semirural, biracial community of Bogalusa, LA (Bogalusa
Heart Study, 1995). Between September 1995 and December
1996, 1420 individuals (1011 whites, 409 African Americans)
were examined for CV risk factors. The LTL data were derived
from 485 individuals of this cohort who had stored blood
available (301 women, 184 men, 247 whites and 138 African
Americans) with an age range of 19–37 years.
The study protocol was approved by Institutional Review
Boards of centers that oversee each of the participating cohorts
and each participant gave written informed consent.
Telomere length measurements
The mean length of the TRFs, determined by Southern blot ana-
lysis, was used to measure LTL on DNA extracted from peripheral
leukocytes. We obtained the mean TRF length in two ways: our
standard method (Okuda et al., 2002) and an ‘overlay’ method
(Vasan et al., in press), both utilizing HinfI/RsaI restriction enzymes.
(Description of the ‘overlay’ method, used for DNA samples
derived from the FHS, is provided in the Supplementary Appendix
S1.) For the standard method, the coefficient of variation for
duplicate samples, which were resolved on different gels, was
1.43% while for the overlay method it was 2.40%. The correlation
between the two methods was r = 0.99, p < 0.0001 (n = 24).
In a subset of participants, TRF length was also measured in DNA
digested with restriction enzymes HphI/MnII. The TRF length
derived from these restriction enzymes highly correlated with
that derived from HinfI/RsaI (r = 0.814, p = 0.0001; Supplementary
Fig. S1). In the same subset we also measured telomere repeats
by qPCR, using minor modification (Gardner et al., 2007) of the
method originally described by Cawthon (2002). The coefficient
of variation for duplicate samples undergoing qPCR on different
days was 6.10%. The laboratory that conducted the TRF length
and qPCR assays was blinded to the identity of the subjects.Race and leukocyte telomere length, S. C. Hunt et al.
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Statistical analyses
The primary analysis consisted of comparing LTL parameters
between African Americans and whites, and between men and
women after adjustment for age and BMI. To investigate cross-
sectional, race-specific associations of age with LTL, sex- and
BMI-adjusted LTLs from each study were combined and analyzed
by generalized estimating equations and an exchangeable
correlation matrix (PROC GENMOD in SAS) to correct the
estimated standard errors for the relatedness of the subjects
within families. This correction prevents inflated significance
levels of the tests used in the analyses presented. An age-by-race
interaction term was included in the model to test if there were
different age-related cross-sectional rates of LTL shortening
between the two races. When significant, this interaction term
was replaced by nesting age within race to estimate the two
different slopes and their standard errors. Sex-by-age interactions
with LTL shortening were not significant. Race-specific heritabilities
of LTL in the FHS were obtained from SOLAR (Almasy & Blangero,
1998), adjusting for sex, age and specific gel on which the sam-
ple was run. Unless otherwise indicated, data are presented as
mean ± SEM.
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